Menu ×


Oncolytic Virotherapy Market Segmentation by Cancer Type (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, and Others); and by Application (General Medical & Surgical Hospitals, Specialty Hospitals, Clinics, and Others) – Global Demand Analysis and Opportunity Outlook 2022-2030

  • Text Size:

Extensive insights into the Growth of Oncolytic Virotherapy Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

Oncolytic Virotherapy Market Highlights 2022-2030

The oncolytic virotherapy market is estimated to grow with a high CAGR during the forecast period, i.e., 2022-2030. Extensive research associated with cancer treatment in western countries, along with the rising prevalence of cancer on a global level are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as gradual rise in interest of researchers towards oncolytic virotherapy due to successful results of its use as a part of immunotherapy in cancer treatment. According to the data collected from International Agency for Research on Cancer (IARC), in 2020, the projected new cases and deaths from cancer globally were 19.3 million and 10 million, respectively.


The market is segmented based on cancer type into melanoma, prostate cancer, breast cancer, ovarian cancer and others, out of which, the breast cancer segment is anticipated to grab the largest share by the end of 2022 on account of being the most common kind of cancer worldwide. Moreover, oncolytic virotherapy is widely being used for increased treatment efficacy for advanced breast cancer and thus, provides a unique platform for personalized treatments in patients.

On the basis of application, the specialty hospitals segment in the oncolytic virotherapy market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that a large section of population choose this segment for cancer treatment as specialty hospitals have well trained healthcare providers specialized for this treatment.  CLICK TO DOWNLOAD SAMPLE REPORT

Oncolytic Virotherapy Market Regional Synopsis

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the increasing awareness about cancer and the need to develop innovative cancer treatment solutions in the region. Furthermore, in 2022, the market in North America is evaluated to occupy the largest share in terms of revenue, owing to the growing investment of governmental and non-governmental agencies in cancer research, accompanied by the presence of leading healthcare service providers in the region. Along with this, the North America also leads in terms of ongoing clinical trials, which is also expected to contribute to the market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the oncolytic virotherapy market on account of its success in terms of clinical trials and a high prevalence of cancer in the region. As per the analysis of World Health Organization, Europe has only one eighth of the total global population but has around one fourth of the world’s total number of cancer cases with around 3.7 million new patients every year.


The oncolytic virotherapy market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global oncolytic virotherapy market includes the following segments:

By Cancer Type

  • Melanoma
  • Prostate Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Others

By Application

  • General Medical & Surgical Hospitals
  • Specialty Hospitals
  • Clinics
  • Others

Growth Drivers

  • Extensive Research Associated with Cancer Treatment in Western Countries
  • Rising Prevalence of Cancer on a Global Level


  • Number of Oncolytic Virotherapy Treatments are Currently in Clinical Trial Phase
  • Lack of Awareness About Cancers in Lower Economic Regions

Top Featured Companies Dominating the Market

  • Amgen, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Oncolytics Biotech
  • Viralytics Ltd.
  • Transgene SA
  • Shanghai Sunway Biotech Co. Ltd.
  • Replimune Group, Inc.
  • Sorrento Therapeutics, Inc.
  • SillaJen, Inc.
  • Oncorus, Inc.


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved